BSX EBITDA Margin
Boston Scientific · EBITDA Margin
BSX EBITDA Margin
Latest reported27.64%period ending
BSX TTM EBITDA Margin (30.68% → 27.64%)
TTM ebitda margin
High-resolution chart · PNG
BSX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 27.6386% | |
| 27.4509% | |
| 26.2665% | |
| 25.9587% | |
| 25.4785% | |
| 23.6826% | |
| 23.4325% | |
| 23.4947% | |
| 24.0084% | |
| 24.7433% | |
| 24.2346% | |
| 24.155% | |
| 21.9478% | |
| 21.7555% | |
| 21.8183% | |
| 19.957% | |
| 22.3538% | |
| 21.0821% | |
| 21.2063% | |
| 23.1581% | |
| 17.5152% | |
| 16.3209% | |
| 13.7395% | |
| 11.9189% | |
| 14.8947% | |
| 16.679% | |
| 20.557% | |
| 22.5751% | |
| 26.1858% | |
| 28.0668% | |
| 26.2954% | |
| 25.5843% | |
| 24.2447% | |
| 21.9296% | |
| 22.1731% | |
| 21.0759% | |
| 20.6932% | |
| 15.1829% | |
| 14.56% | |
| 9.6782% | |
| 2.0488% | |
| 9.0968% | |
| 5.323% | |
| 2.1527% | |
| 6.8764% | |
| 3.2682% | |
| 5.7995% | |
| 14.1181% | |
| 14.8061% | |
| 18.5299% | |
| 11.0318% | |
| 11.0721% | |
| 1.263% | |
| -52.4703% | |
| -45.4483% | |
| -45.7331% | |
| -35.4504% | |
| 15.2453% | |
| 17.6332% | |
| 19.8688% | |
| 21.2075% | |
| 21.5802% | |
| -2.0113% | |
| -21.8191% | |
| -24.1491% | |
| -23.0769% | |
| -4.7753% | |
| -18.0989% | |
| -18.1796% | |
| -17.4694% | |
| -12.646% | |
| 13.2545% | |
| 12.03% | |
| 11.5533% | |
| 10.5647% | |
| 17.0496% | |
| 20.308% | |
| 19.3315% | |
| 21.7364% | |
| 23.8898% | |
| 16.3103% | |
| 20.8969% | |
| 22.2187% | |
| 22.513% | |
| 33.402% | |
| 33.8152% | |
| 31.1344% | |
| 29.0752% | |
| 28.7583% | |
| 24.5535% | |
| 23.6766% | |
| 24.2316% | |
| 27.3694% | |
| 26.647% | |
| 26.2761% | |
| 34.7951% | |
| 30.5861% | |
| 29.1388% | |
| 29.3678% | |
| 23.4624% |